JP2012525346A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525346A5
JP2012525346A5 JP2012507703A JP2012507703A JP2012525346A5 JP 2012525346 A5 JP2012525346 A5 JP 2012525346A5 JP 2012507703 A JP2012507703 A JP 2012507703A JP 2012507703 A JP2012507703 A JP 2012507703A JP 2012525346 A5 JP2012525346 A5 JP 2012525346A5
Authority
JP
Japan
Prior art keywords
bordetella pertussis
live
vaccine according
attenuated bordetella
pertussis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012507703A
Other languages
English (en)
Japanese (ja)
Other versions
JP5678034B2 (ja
JP2012525346A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/055507 external-priority patent/WO2010125014A1/en
Publication of JP2012525346A publication Critical patent/JP2012525346A/ja
Publication of JP2012525346A5 publication Critical patent/JP2012525346A5/ja
Application granted granted Critical
Publication of JP5678034B2 publication Critical patent/JP5678034B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012507703A 2009-04-28 2010-04-26 アレルゲン駆動性気道病態の予防または治療のためのワクチン Active JP5678034B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305371 2009-04-28
EP09305371.8 2009-04-28
PCT/EP2010/055507 WO2010125014A1 (en) 2009-04-28 2010-04-26 Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

Publications (3)

Publication Number Publication Date
JP2012525346A JP2012525346A (ja) 2012-10-22
JP2012525346A5 true JP2012525346A5 (cg-RX-API-DMAC7.html) 2013-05-02
JP5678034B2 JP5678034B2 (ja) 2015-02-25

Family

ID=41057387

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012507703A Active JP5678034B2 (ja) 2009-04-28 2010-04-26 アレルゲン駆動性気道病態の予防または治療のためのワクチン

Country Status (10)

Country Link
US (7) US20120177688A1 (cg-RX-API-DMAC7.html)
EP (3) EP2910252A1 (cg-RX-API-DMAC7.html)
JP (1) JP5678034B2 (cg-RX-API-DMAC7.html)
CN (1) CN102448490B (cg-RX-API-DMAC7.html)
AU (1) AU2010243708C1 (cg-RX-API-DMAC7.html)
CA (1) CA2759280C (cg-RX-API-DMAC7.html)
DK (1) DK2424564T3 (cg-RX-API-DMAC7.html)
ES (2) ES3024937T3 (cg-RX-API-DMAC7.html)
SG (1) SG175803A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010125014A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1994139B1 (en) * 2006-03-10 2016-07-13 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
CN102448490B (zh) 2009-04-28 2015-05-13 国家健康与医学研究院 用于预防或治疗过敏原引起的气道疾病的疫苗
DK2442826T3 (en) 2009-06-15 2015-09-21 Univ Singapore Influenza vaccine, composition and methods of using
SG11201401904YA (en) 2011-11-02 2014-05-29 Univ Singapore Effect of an attenuated bordetella strain against allergic disease
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
ES2864667T3 (es) 2013-08-16 2021-10-14 Univ Rochester Péptidos diseñados para la modulación de la barrera de unión estrecha
US9655959B2 (en) * 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
WO2017167834A1 (en) * 2016-03-29 2017-10-05 Institut Pasteur De Lille Mutant bordetella strains and methods for use
JP6598724B2 (ja) 2016-04-07 2019-10-30 株式会社ジェイテクト ステアリング装置
WO2019077028A1 (en) 2017-10-18 2019-04-25 Institut Pasteur De Lille BORDETELLA STRAINS EXPRESSING SERO-TYPE FIMBRIAE 3
EP3980054A1 (en) 2019-06-05 2022-04-13 University Of Rochester New designed inhibitors of tight junction formation
EP4208472A1 (en) * 2020-09-04 2023-07-12 Intravacc B.V. Ompa mutations enhance omv production in bordetella pertussis
EP3909971A1 (en) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Whole cell livestock vaccine for respiratory diseases

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883761A (en) 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) * 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
WO2004091519A2 (en) * 2003-04-11 2004-10-28 Medimmune, Inc. Methods of preventing or treating respiratory conditions
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
EP1994139B1 (en) 2006-03-10 2016-07-13 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
WO2008118592A2 (en) 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
CN100537767C (zh) * 2007-04-29 2009-09-09 中国药品生物制品检定所 百日咳疫苗保护性抗原的重组表达及其应用
CN102448490B (zh) 2009-04-28 2015-05-13 国家健康与医学研究院 用于预防或治疗过敏原引起的气道疾病的疫苗
CN101947323B (zh) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 一种革兰氏阴性细菌疫苗及其制备方法
SG11201401904YA (en) 2011-11-02 2014-05-29 Univ Singapore Effect of an attenuated bordetella strain against allergic disease
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
WO2017167834A1 (en) 2016-03-29 2017-10-05 Institut Pasteur De Lille Mutant bordetella strains and methods for use
US10799573B2 (en) 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
US20200171169A1 (en) 2017-05-15 2020-06-04 Vanderbilt University LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY
WO2019016654A1 (en) 2017-07-18 2019-01-24 Serum Institute Of India Pvt Ltd. IMMUNOGENIC COMPOSITION WITH IMPROVED STABILITY, ENHANCED IMMUNOGENICITY, AND LESS REACTOGENICITY, AND PREPARATION METHOD THEREOF
WO2019077028A1 (en) 2017-10-18 2019-04-25 Institut Pasteur De Lille BORDETELLA STRAINS EXPRESSING SERO-TYPE FIMBRIAE 3
US12036405B2 (en) 2018-03-23 2024-07-16 The Board Of Regents Of The University Of Oklahoma System and method of electric-induced acoustic tomography for electrotherapy monitoring

Similar Documents

Publication Publication Date Title
JP2012525346A5 (cg-RX-API-DMAC7.html)
Kong et al. Successful treatment of avian influenza with convalescent plasma
PH12019500289A1 (en) Vaccines directed against a human enteroviruses
US20080066739A1 (en) Methods and systems of delivering medication via inhalation
GEP20227366B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
JP2012500004A5 (cg-RX-API-DMAC7.html)
EP2749284A3 (en) Combination of glycopyrronium and carmoterol
JP2015536134A5 (cg-RX-API-DMAC7.html)
JP2013510169A5 (cg-RX-API-DMAC7.html)
CN103002896A (zh) 左西替利嗪和孟鲁司特在治疗流感、普通感冒和炎症中的用途
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
JP2012527218A5 (cg-RX-API-DMAC7.html)
EA201201392A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
JP2014511897A5 (cg-RX-API-DMAC7.html)
Laiño et al. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
ATE410163T1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
JP2014520854A5 (cg-RX-API-DMAC7.html)
JP2011068643A5 (cg-RX-API-DMAC7.html)
JP2010523662A5 (cg-RX-API-DMAC7.html)
Moinho Pneumococcal 13 valent CRM197 vaccine conjugate/pneumococcal 7 valent CRM197 vaccine conjugate
Lusuardi Challenging mucosal immunity with bacterial extracts to prevent respiratory infections: an old therapy revisited
Burns et al. Wean earlier and automatically with new technology: preliminary results of the wean study
Claude et al. B32 VIRAL INFECTION OF THE AIRWAY: Development Of Infant Respiratory Distress Syndrome In Response To Influenza A/pr/8/34 Infection
Kim et al. Polysomnographic Parameters Related to the Successful Treatment of Oral Appliance in Patients with Sleep-Disordered Breathing.